ACTRN12610000787088已完成4 期
Prevention of Cytomegalovirus (CMV) disease in liver transplant patients: studies of antiviral prophylaxis and pre-emptive therapy.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Male or female > 16 years of age
- •2. Patients undergoing liver transplantation
- •3. Single or multi-organ transplant
- •4. Patients meet transplant criteria
- •5. Chronic liver disease or fulminant hepatic failure
- •6. Able to give written informed consent
排除标准
- •1. Patients under the age of 16 years
- •2. History of hypersensitivity to ganciclovir or valganciclovir
- •3. Patients involved in any other clinical trials
- •4. Patients taking any other investigational drugs within 2 months prior to the study screening.
- •5. Use of any other antiviral therapy against herpes virus within 2 months prior to transplant will be noted and this population analysed as a subgroup
- •6. Patients unable to give consent
- •7. Inadequate renal function defined as creatinine clearance < 10 mL/sec
研究者
相似试验
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 18.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-DEBiotest AG16,000
进行中（未招募）
1 期
Prevention of congenital CMV infection in infants of mothers with primary CMV infection during pregnancyCONGENITAL CMV INFECTION IN NEWBORN FROM MOTHERS WITH PRIMARY CMV INFECTION DURING PREGNANCYMedDRA version: 14.1Level: SOCClassification code 10010331Term: Congenital, familial and genetic disordersSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.1Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2007-004692-19-ITBIOTEST AG25,000
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 17.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-HUBiotest AG15,474
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)Congenital CMV infection after primary CMV infection during pregnancyMedDRA version: 19.0Level: LLTClassification code 10010420Term: Congenital CMV infectionSystem Organ Class: 100000004850EUCTR2007-004692-19-ATBiotest AG16,000
进行中（未招募）
1 期
Prevention of congenital cytomegalovirus infection in infants of mothers with primary cytomegalovirus infection during pregnancy. A randomised, open, controlled, multicentre and multinational study investigating efficacy and safety of Cytotect FH, nanometer filtered (BT094)EUCTR2007-004692-19-BEBiotest AG16,000